Russia Churns Out Skolkovo as Latest R&D Innovation Hub
24 December 2013
Skolkovo, a 100-acre industrial park and business incubator on the outskirts of Moscow, recently re-elected the Prime Minister of the Russian Federation, Dmitry Medvedev, as Skolkovo Foundation chairman.
26 November 2013
Preference of 15% can get the company that packaged medicines in Russia ( these preferences will be valid until the end of 2014 - after such producers cease to be considered local , say two members of yesterday's meeting at Manturov), 30 % - manufacturers of finished dosage forms , 40 % - establish a complete production cycle , ie, including the production of substances.
Russia's healthcare system coping with modern challenges
05 November 2013
According to the Ministry of Public Health and Social Development, Russians can obtain at home most of the same aid available on the global healthcare market.
Business Council Meeting Sees Two New Partnerships
05 November 2013
Russian government officials, led by two deputy ministers, met with U.S. business representatives and lobbyists for a two-day conference in Houston to exchange their views on doing business in Russia.
Russia best place for investments – medical company executive
05 November 2013
As the "Open Innovations" Forum in Moscow is in full swing presenting new cutting edge technologies, Steven Oesterle, Senior Vice President of Corporate Strategy and Innovation at Medtronic Inc., in an interview to Voice of Russia outlined what his company has to contribute to the global development of technology.
Evaluation of Russian pharmaceutical market
30 October 2013
The company " Coface ", which is an expert in the field of commercial risks and the global leader in credit insurance , has introduced the first quarterly report on the evaluation of the Russian pharmaceutical market . Estimation of capacity of the pharmaceutical market as a whole and its individual elements may vary depending on the source of the information . This is due to the fact that different media outlets can use divergent ways of grouping types of pharmaceutical activity by sector. The ratio of domestic and imported drugs in the Russian market remained stable in 2011 - 1 half of 2013 , and in value terms, imports cover about 75 % of the market , and in-kind - only 40% ( in 2011 the share of slightly shifted in favor of imported goods).
VC funding follows tepid pace in Q3 as first-time biotech rounds shrive
21 October 2013
Biotech companies in the U.S. drew a weak $852 million in venture support over the past quarter, a distinct downturn over a burst of new financing rounds in the second quarter. That dollar figure represented a 39% plunge from the second quarter, though the smaller bankroll was divided among 123 deals, with a 10% jump in the number of companies involved.
Russia: pharma sales "to grow 11% this year"
21 October 2013
Pharmaceutical sales in Russia are expected to reach $24.29 billion this year from $22.22 billion in 2012, which is up 9.3% in US dollars and 11% in local currency terms, says new research.
FierceMedicalDevices' 2013 Fierce 15
21 October 2013
This year's crop endured the struggles many startups face and came out ahead. They've attracted substantial funding from major investors in a tough market, proving the worth of their products. Many are also already in--or close to--market with their signature products, a sign of stability that draws investor commitments much more these days than companies on the earlier side of development.
“Rusnano” established the managing company for itself
21 October 2013
The Board of directors of “Rosnano”, OJSC has approved a deal, foreseeing investment of 990K RUB in the charter capital of the established “Managing Company “Rosnano”, LLC. In future it will become private, and the idea of privatization of “Rosnano” recedes into the past. The Managing Company is established in accordance with approved in June, 2012 new strategy of “Rosnano”, the core of which is separation of management functions and assets owning.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024